Litcius/Paper detail

Clinical Utility and Performance of an Ultrarapid Multiplex RNA-Based Assay for Detection of ALK, ROS1, RET, and NTRK1/2/3 Rearrangements and MET Exon 14 Skipping Alterations

Ying‐Hsia Chu, Jada Barbee, Soo‐Ryum Yang, Jason C. Chang, Priscilla Liang, Kerry Mullaney, Roger Chan, Paulo Salazar, Ryma Benayed, Michael Offin, Alexander Drilon, Marc Ladanyi, Khédoudja Nafa, Maria E. Arcila

2022Journal of Molecular Diagnostics17 citationsDOIOpen Access PDF

Topics & Concepts

ROS1ExonMultiplexMolecular biologyCancer researchBiologyMedicineComputational biologyGeneticsGeneCancerAdenocarcinomaLung Cancer Treatments and MutationsGenetic factors in colorectal cancerCancer Genomics and Diagnostics
Clinical Utility and Performance of an Ultrarapid Multiplex RNA-Based Assay for Detection of ALK, ROS1, RET, and NTRK1/2/3 Rearrangements and MET Exon 14 Skipping Alterations | Litcius